Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases

doi:10.3748/wjg.v18.i36.5065

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3442)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

414

HTML

2733

Figures (1-4)

164

Tables (1-2)

131

Sum=3442

Sep 28, 2012 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 28, 2012; 18(36): 5065-5071
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5065

Full Size Figure Download Figure

Figure 3 Histological samples before and after therapy. A: Biopsy specimen showing crypt abscess and perycriptitis (histological grade 2); B: Biopsy specimen morphologically indistinguishable from normal intestinal mucosa (histological grade 0).

Citation: Merra G, Gasbarrini G, Laterza L, Pizzoferrato M, Poscia A, Scaldaferri F, Arena V, Fiore F, Cittadini A, Sgambato A, Franceschi F, Gasbarrini A. Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases. World J Gastroenterol 2012; 18(36): 5065-5071
URL: https://www.wjgnet.com/1007-9327/full/v18/i36/5065.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i36.5065